Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Diabetes Care

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.22.4.603PMID 10189539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment

  1997cited by this paper
• Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.

  1997cited by this paper
• Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

  1997cited by this paper
• Mixing Insulin Lispro and Ultralente Insulin

  1997cited by this paper
• Insulin Lispro in CSII: Results of a Double-Blind Crossover Study

  1997cited by this paper
• Strategies Toward Improved Control During Insulin Lispro Therapy in IDDM: Importance of basal insulin

  1997cited by this paper
• Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics.

  1989cited by this paper
• The physiologic replacement of insulin. An elusive goal.

  1989cited by this paper
• A Comparison of Morning and Bed‐time Ultralente Administration When Using Multiple Injections in Adolescence

  1988cited by this paper
• Human, Porcine and Bovine Ultralente Insulin: Subcutaneous Administration in Normal Man

  1986cited by this paper

• Trends in baseline HbA1c and body-mass index in randomised trials of people with type 1 diabetes from 1993 to 2025: an IMI2 SOPHIA systematic review and meta-analysis

  2025cites this paper
• The ongoing evolution of basal insulin therapy over 100 years and its promise for the future

  2021cites this paper
• Insulin and insulin analogs as antidiabetic therapy: A perspective from clinical trials.

  2021cites this paper
• Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls

  2017cites this paper
• Chapter 44 – Treatment of Type 1 Diabetes Mellitus in Adults

  2016cites this paper
• Type 1 Diabetes in Adults

  2010cites this paper
• Intermediate acting versus long acting insulin for type 1 diabetes mellitus.

  2008cites this paper
• Insulin Glargine in the Treatment of Type 1 and Type 2 Diabetes

  2006influential citation
• Type 1 Diabetes in Children, Adolescents, and Young Adults: How to Become an Expert on Your Own Diabetes

  2006cites this paper
• Insulin Strategies for Type 2 Diabetes Mellitus

  2004cites this paper
• Using Insulin Effectively in the Management of Diabetes

  2004cites this paper
• Functional intensified insulin therapy with short-acting insulin analog: effects on HbA1c and frequency of severe hypoglycemia. An observational cohort study.

  2003cites this paper
• A review of basal insulins

  2003cites this paper
• Effects of Rapid-Acting Insulin Analogs on Overall Glycemic Control in Type 1 and Type 2 Diabetes Mellitus

  2003cites this paper
• The use of information technology for the management of intensive insulin therapy in type 1 diabetes mellitus.

  2003cites this paper
• Insulin Regimens for Type 1 Diabetes

  2003cites this paper
• Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus

  2003cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Is the use of insulin lispro safe in pregnancy?

  2002cites this paper
• Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.

  2002cites this paper
• Basal insulin—answers from analogues?

  2002cites this paper
• Insulins today and beyond.

  2001cites this paper
• Revisão da hiperglicemia pós-prandial e a hipoglicemia no controle do diabetes mellitus: o papel da insulina lispro e suas pré-misturas nos picos e vales

  2001cites this paper
• The use of human ultralente is limited by great intraindividual variability in overnight plasma insulin profiles

  2000cites this paper
• Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

  2000cites this paper
• Basal insulin replacement and use of rapid-acting insulin analogues in patients with type 1 diabetes.

  2000cites this paper
• A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

  2000cites this paper
• Insulin analogues and their potential in the management of diabetes mellitus

  1999cites this paper
• The human insulin analogue insulin lispro.

  1998cites this paper